Dr. Jennifer L. Defazio, MD

Dr. Defazio practices at Memorial Sloan-Kettering Cancer Center Suffolk at Hauppauge in New York, New York.

Dr. Defazio's NPI, 1255443925, was assigned on August 31, 2006. Dr. Defazio graduated from Jacobs School of Medicine and Biomedical Sciences in 2002. Dr. Defazio's New York license number on file is 240844.

Dr. Defazio's primary practice is Memorial Sloan-Kettering Cancer Center Suffolk at Hauppauge, at 633 3rd Ave, New York, NY 10017 in New York County. The practice phone is (212) 639-2000.

Dr. Defazio's primary practice is Memorial Sloan-Kettering Cancer Center Suffolk at Hauppauge in New York, New York. Dr. Defazio is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Defazio to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Defazio practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Defazio's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Defazio is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Defazio's licenses on file in 2 states: New York and Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes, joint cyst and minor head injury among the conditions Dr. Defazio treats.

CMS data shows 4,021 Medicare services from Dr. Defazio across 15 procedure codes in 2024, for 1,035 Medicare patients. Medicare paid $255,328 for them. Every service was in an office.

CMS counts 1,035 Medicare patients who saw Dr. Defazio in 2024. The largest group is 75 to 84, with 440 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Defazio's median patient age at 71, with 61% women.

In 2024, Dr. Defazio wrote 718 Medicare Part D claims for 365 patients. 89% of them were for generic drugs. CMS names the drug for 612 of them, across 13 drugs with 11 or more claims each, at $90,772 in total drug cost. In 2023, CMS named 651 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Defazio for performance year 2024, reported as part of a group. Dr. Defazio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 652 procedures of skin biopsy by Dr. Defazio, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Defazio, published from 2010 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Melanoma and Dermoscopy. Dr. Defazio has published most often in Dermatol Pract Concept. Dr. Defazio's most frequent co-authors are Ashfaq A. Marghoob, MD, Allan C. Halpern, MD and Zaeem Nazir, MD.

CMS Open Payments shows 1 general payment to Dr. Defazio from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Organogenesis Inc. paid the most, $20.

Dmand AI lists 1 award for Dr. Defazio.

Dr. Defazio graduated from Jacobs School of Medicine and Biomedical Sciences in 2002. Dr. Defazio is a member of AAD.

Dr. Defazio is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.